Казанский государственный медицинский институт им.С.В.Курашова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Казанский государственный медицинский институт им.С.В.КурашоваfiledCriticalКазанский государственный медицинский институт им.С.В.Курашова
Priority to SU3962324/14ApriorityCriticalpatent/SU1744810A1/en
Application grantedgrantedCritical
Publication of SU1744810A1publicationCriticalpatent/SU1744810A1/en
FIELD: medicine. SUBSTANCE: method involves the use of 1,1-dimethyl-3-oxobutylphosphonic acid dimethyl ester as a vasoactive agent showing ability to normalize functions of vegetative nervous system. Early this agent was used as antiacidemic drug. EFFECT: elimination of by-side effects.
SU3962324/14A1985-10-011985-10-01Vasoactive agent "dimephosphone" normalizing vegetative nervous system functions
SU1744810A1
(en)